High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes

Published:2017-07 Issue:1 Volume:124 Page:49-55
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Vigneault Eric,Mbodji Khaly,Magnan Sindy,Després Philippe,Lavallée Marie-Claude,Aubin Sylviane,Beaulieu Luc,Foster William,Martin André-Guy

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference32 articles.

1. Canadian Cancer Statistics 2016;Canadian Cancer Society’s Advisory Committee on Cancer Statistics,2016

2. Clinical practice. Localized prostate cancer;Walsh;N Engl J Med,2007

3. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial;Hoskin;Radiother Oncol,2007

4. Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study;Mahmoudieh;Radiother Oncol,2005

5. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome;Bachand;Int J Radiat Oncol Biol Phys,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy: The urologist opinion;Urologia Journal;2024-02

2. Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group;Radiotherapy and Oncology;2023-03

3. Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy;International Journal of Clinical Oncology;2023-02-22

4. Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial;Brachytherapy;2023-01

5. Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer;Acta Oncologica;2022-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3